Subscribe

Jens Hillengass, MD

Articles by Jens Hillengass, MD

Cell Therapy May Yield Deep Remissions in Multiple Myeloma

ByPhilip McCarthy, MD,Jens Hillengass, MD

November 1st 2021

Ide-cel's March 2021 FDA approval marks a significant advance in relapsed/refractory multiple myeloma treatment.

Latest Updated Articles

Trending on CGTlive®

CGTLive®’s Weekly Rewind – October 24, 2025

© 2025 MJH Life Sciences^®

All rights reserved.